Metrovacesa (Spain) Performance
| MVC Stock | EUR 10.00 0.15 1.48% |
The company secures a Beta (Market Risk) of 0.0225, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Metrovacesa's returns are expected to increase less than the market. However, during the bear market, the loss of holding Metrovacesa is expected to be smaller as well. At this point, Metrovacesa SA has a negative expected return of -0.0488%. Please make sure to verify Metrovacesa's daily balance of power, market facilitation index, and the relationship between the kurtosis and day median price , to decide if Metrovacesa SA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Metrovacesa SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Metrovacesa is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 334 M | |
| Total Cashflows From Investing Activities | -3.8 M |
Metrovacesa |
Metrovacesa Relative Risk vs. Return Landscape
If you would invest 1,040 in Metrovacesa SA on April 28, 2025 and sell it today you would lose (40.00) from holding Metrovacesa SA or give up 3.85% of portfolio value over 90 days. Metrovacesa SA is producing return of less than zero assuming 1.5314% volatility of returns over the 90 days investment horizon. Simply put, 13% of all stocks have less volatile historical return distribution than Metrovacesa, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Metrovacesa Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Metrovacesa's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Metrovacesa SA, and traders can use it to determine the average amount a Metrovacesa's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0319
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MVC |
Estimated Market Risk
| 1.53 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Metrovacesa is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Metrovacesa by adding Metrovacesa to a well-diversified portfolio.
Metrovacesa Fundamentals Growth
Metrovacesa Stock prices reflect investors' perceptions of the future prospects and financial health of Metrovacesa, and Metrovacesa fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Metrovacesa Stock performance.
| Return On Equity | 0.012 | |||
| Return On Asset | 0.014 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 1.04 B | |||
| Shares Outstanding | 151.45 M | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 1.85 X | |||
| Revenue | 510.74 M | |||
| EBITDA | 33.76 M | |||
| Cash And Equivalents | 117.2 M | |||
| Cash Per Share | 0.77 X | |||
| Total Debt | 287.44 M | |||
| Debt To Equity | 3.20 % | |||
| Book Value Per Share | 13.24 X | |||
| Cash Flow From Operations | 138.97 M | |||
| Earnings Per Share | 0.16 X | |||
| Total Asset | 2.78 B | |||
About Metrovacesa Performance
By analyzing Metrovacesa's fundamental ratios, stakeholders can gain valuable insights into Metrovacesa's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Metrovacesa has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Metrovacesa has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Metrovacesa S.A. operates as a real estate development company in Spain. The company was incorporated in 1935 and is based in Madrid, Spain. METROVACESA operates under Real Estate - General classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1 people.Things to note about Metrovacesa SA performance evaluation
Checking the ongoing alerts about Metrovacesa for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Metrovacesa SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Metrovacesa SA generated a negative expected return over the last 90 days | |
| About 94.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Metrovacesa's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Metrovacesa's stock is overvalued or undervalued compared to its peers.
- Examining Metrovacesa's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Metrovacesa's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Metrovacesa's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Metrovacesa's stock. These opinions can provide insight into Metrovacesa's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Metrovacesa Stock analysis
When running Metrovacesa's price analysis, check to measure Metrovacesa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Metrovacesa is operating at the current time. Most of Metrovacesa's value examination focuses on studying past and present price action to predict the probability of Metrovacesa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Metrovacesa's price. Additionally, you may evaluate how the addition of Metrovacesa to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |